Neurological Biomarkers Industry Report- Revenue, Opportunity Assessment, Future Trends, Y-O-Y Growth Rate, Demand, Segmentation (By Type, By Product Type, By Application, By End-User) Market Data 2017-2025

Neurological Biomarker Market in the Global Industry Landscape

Neurology is still a complicated segment and thus the neurological biomarkers application is growing at high rate among not only the clinical practitioners but also for the experimental purposes. Increasing usage of metabolomics, proteomics, genomics, and bioinformatics along with the advanced technologies and investments from the government and private players is driving the growth of the market. Further, obesity is one the major cause in the development of diseases and other problems in the central nervous system (CNS). As per WHO, globally 1.4 billion adults are overweight with highest population in the developed and developing countries. Rate of obesity is growing at a fast pace in the developing countries. Moreover, the diagnostic application of neurological biomarkers is facing slow growth as compared to high rate of drug discovery and development applications. The personalized medication is a new trend in the application of neurological biomarker. Moreover, the personalized medication using biomarkers are witnessing tremendous positive outcomes in the cases of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease (PD).

Our Global Neurological Biomarker Market can be segmented on the following basis:

By Type

• Disease Related Biomarker
  • Diagnostic Biomarker
  • Prognostic Biomarker
• Drug Related Biomarker
• Imaging Biomarker
• Molecular Biomarker
• Surrogate Biomarker
• Others

By Product Type

• Hormones
• Enzymes
• Antibodies
• Gene products
• Others

By Application

• Drug Discovery and Development
• Disease Diagnosis
• Genetic Studies
• Molecular Diagnostics
• Bioinformatics
• Others (Forensic Application, etc.)

By End-User

• Pharmaceutical Companies
• Hospitals
• Research Labs and Institutes
• Others

Global Neurological Biomakers Market Outlook comprises of the following data:

• Coverage Numbers and Type of Neurological biomarkers in Clinical Use, 2012-2017
• Coverage Numbers and Type of Neurological biomarkers Under Trials, 2015-2018
• Sales of Neurological Biomarkers by Application, 2016-2025
• Sales of Neurological Biomarkers by End-User, 2016-2025
• Number of Patients Suffering from Brain Tumor, 2015 and 2016-2025

In 2016 on the basis of application, drug discovery and development segment accounted for largest market share due to increasing number of Neurodegenerative Disease cases. Knowing the root cause of the disease and its solution is most effective by the use of personalized medication using biomarkers.

Multiple sclerosis (MS) is a deep-rooted disorder of the CNS. Among the young adults it is the most common cause of neurological disability majorly in the Northern Europe, North America, and similar temperate latitudes. The course of medication is difficult to perform and thus the surrogate endpoints prove to be very useful to carry out clinical trials and course of medication.

For a full detailed overview, send us the sample request.

Key questions answered in this Global Neurological Biomarkers Industry Report

• What is the total market size by 2025 and what would be the expected growth rate of CNS Biomarkers Market?
• What is the total revenue per segment and region in 2017-18 and what would be the expected revenue per segment and region over the forecast period?
• What are the key CNS Biomarkers market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Neurological Biomarkers market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Neurological Biomarkers market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects
• Complete overview and insightful data on CNS Biomarkers Market